| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community Health Centers | 33 | 2023 | 112 | 9.320 |
Why?
|
| Electronic Health Records | 37 | 2023 | 747 | 5.550 |
Why?
|
| Insurance Coverage | 22 | 2018 | 136 | 5.040 |
Why?
|
| Insurance, Health | 18 | 2018 | 217 | 4.190 |
Why?
|
| Primary Health Care | 25 | 2023 | 848 | 3.780 |
Why?
|
| Health Services Accessibility | 20 | 2020 | 320 | 3.410 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 630 | 2.710 |
Why?
|
| Social Determinants of Health | 9 | 2023 | 47 | 2.680 |
Why?
|
| Medicaid | 20 | 2018 | 211 | 2.580 |
Why?
|
| Humans | 100 | 2024 | 18430 | 2.100 |
Why?
|
| Health Services Needs and Demand | 6 | 2014 | 109 | 1.930 |
Why?
|
| United States | 46 | 2022 | 4164 | 1.810 |
Why?
|
| Delivery of Health Care | 9 | 2023 | 444 | 1.720 |
Why?
|
| Parents | 6 | 2015 | 309 | 1.700 |
Why?
|
| Medically Uninsured | 12 | 2018 | 61 | 1.620 |
Why?
|
| Oregon | 26 | 2017 | 222 | 1.370 |
Why?
|
| Diabetes Mellitus | 9 | 2019 | 530 | 1.370 |
Why?
|
| Young Adult | 29 | 2020 | 2518 | 1.360 |
Why?
|
| Adolescent | 32 | 2020 | 3798 | 1.340 |
Why?
|
| Female | 59 | 2024 | 13136 | 1.330 |
Why?
|
| Medical Informatics | 5 | 2018 | 45 | 1.300 |
Why?
|
| Child Health Services | 6 | 2016 | 129 | 1.270 |
Why?
|
| Child | 26 | 2020 | 2571 | 1.220 |
Why?
|
| Health Services Research | 8 | 2020 | 264 | 1.220 |
Why?
|
| Adult | 40 | 2022 | 7910 | 1.200 |
Why?
|
| Diabetes Complications | 4 | 2017 | 119 | 1.150 |
Why?
|
| Male | 38 | 2023 | 10440 | 1.130 |
Why?
|
| Quality Improvement | 4 | 2017 | 207 | 1.120 |
Why?
|
| Guideline Adherence | 6 | 2019 | 162 | 1.100 |
Why?
|
| Health Policy | 5 | 2017 | 136 | 1.100 |
Why?
|
| Mass Screening | 4 | 2019 | 690 | 1.090 |
Why?
|
| Family Planning Services | 4 | 2017 | 27 | 1.080 |
Why?
|
| Poverty | 9 | 2015 | 182 | 1.040 |
Why?
|
| Pandemics | 3 | 2024 | 292 | 0.990 |
Why?
|
| Research Design | 5 | 2020 | 402 | 0.940 |
Why?
|
| Practice Guidelines as Topic | 6 | 2017 | 333 | 0.930 |
Why?
|
| Middle Aged | 31 | 2022 | 8284 | 0.930 |
Why?
|
| Child, Preschool | 13 | 2020 | 1478 | 0.870 |
Why?
|
| Financing, Government | 4 | 2017 | 32 | 0.870 |
Why?
|
| Quality Indicators, Health Care | 5 | 2015 | 197 | 0.860 |
Why?
|
| Papillomavirus Vaccines | 4 | 2013 | 118 | 0.840 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 95 | 0.830 |
Why?
|
| Community Networks | 2 | 2020 | 28 | 0.830 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2022 | 56 | 0.820 |
Why?
|
| Health Plan Implementation | 2 | 2019 | 41 | 0.810 |
Why?
|
| Safety-net Providers | 4 | 2017 | 63 | 0.770 |
Why?
|
| Quality Assurance, Health Care | 3 | 2012 | 188 | 0.760 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 36 | 0.730 |
Why?
|
| Aged | 20 | 2023 | 6417 | 0.730 |
Why?
|
| Documentation | 2 | 2020 | 45 | 0.720 |
Why?
|
| Betacoronavirus | 1 | 2020 | 36 | 0.710 |
Why?
|
| Comparative Effectiveness Research | 2 | 2019 | 77 | 0.680 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.680 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.680 |
Why?
|
| Unnecessary Procedures | 2 | 2017 | 26 | 0.680 |
Why?
|
| Housing | 1 | 2019 | 40 | 0.670 |
Why?
|
| Hypertension | 1 | 2024 | 524 | 0.650 |
Why?
|
| Infant | 10 | 2020 | 1245 | 0.630 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2018 | 407 | 0.600 |
Why?
|
| Biomedical Research | 3 | 2014 | 93 | 0.590 |
Why?
|
| Pediatrics | 4 | 2015 | 166 | 0.590 |
Why?
|
| Eligibility Determination | 3 | 2014 | 17 | 0.550 |
Why?
|
| Ambulatory Care | 2 | 2018 | 266 | 0.550 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 13 | 0.540 |
Why?
|
| Abortion, Induced | 1 | 2016 | 17 | 0.540 |
Why?
|
| Social Behavior | 1 | 2016 | 24 | 0.540 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 52 | 0.520 |
Why?
|
| Low Back Pain | 1 | 2016 | 55 | 0.520 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 46 | 0.520 |
Why?
|
| Diffusion of Innovation | 1 | 2015 | 44 | 0.510 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 25 | 0.510 |
Why?
|
| Birth Intervals | 2 | 2005 | 10 | 0.500 |
Why?
|
| Patient Protection and Affordable Care Act | 8 | 2016 | 51 | 0.500 |
Why?
|
| Cooperative Behavior | 4 | 2020 | 102 | 0.500 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 112 | 0.470 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 195 | 0.470 |
Why?
|
| Pregnancy | 10 | 2020 | 1516 | 0.470 |
Why?
|
| Immunization Schedule | 2 | 2012 | 133 | 0.460 |
Why?
|
| Retrospective Studies | 13 | 2024 | 2550 | 0.460 |
Why?
|
| Women's Health | 4 | 2013 | 207 | 0.450 |
Why?
|
| Immunization, Secondary | 2 | 2013 | 64 | 0.450 |
Why?
|
| Models, Educational | 1 | 2013 | 7 | 0.450 |
Why?
|
| Evidence-Based Practice | 3 | 2020 | 56 | 0.440 |
Why?
|
| Health Care Reform | 1 | 2013 | 33 | 0.440 |
Why?
|
| Supreme Court Decisions | 1 | 2012 | 2 | 0.430 |
Why?
|
| Reproductive Health | 1 | 2012 | 12 | 0.420 |
Why?
|
| Socioeconomic Factors | 8 | 2020 | 673 | 0.410 |
Why?
|
| Outcome Assessment (Health Care) | 5 | 2017 | 254 | 0.410 |
Why?
|
| Review Literature as Topic | 1 | 2011 | 13 | 0.390 |
Why?
|
| Health Priorities | 1 | 2011 | 28 | 0.390 |
Why?
|
| Health Maintenance Organizations | 5 | 2016 | 479 | 0.390 |
Why?
|
| Primary Prevention | 1 | 2012 | 79 | 0.380 |
Why?
|
| State Health Plans | 4 | 2015 | 44 | 0.380 |
Why?
|
| Process Assessment (Health Care) | 3 | 2018 | 28 | 0.380 |
Why?
|
| School Health Services | 1 | 2011 | 42 | 0.370 |
Why?
|
| Patient Compliance | 1 | 2012 | 318 | 0.360 |
Why?
|
| Surveys and Questionnaires | 5 | 2023 | 1389 | 0.350 |
Why?
|
| Program Evaluation | 4 | 2020 | 244 | 0.350 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 182 | 0.340 |
Why?
|
| Infant, Newborn | 5 | 2020 | 872 | 0.330 |
Why?
|
| Health Status | 2 | 2013 | 328 | 0.330 |
Why?
|
| Information Dissemination | 3 | 2020 | 57 | 0.330 |
Why?
|
| Preventive Health Services | 3 | 2015 | 166 | 0.320 |
Why?
|
| Age Factors | 6 | 2020 | 965 | 0.320 |
Why?
|
| Social Class | 2 | 2013 | 125 | 0.300 |
Why?
|
| Computer Communication Networks | 2 | 2020 | 18 | 0.300 |
Why?
|
| Environment Design | 3 | 2013 | 68 | 0.300 |
Why?
|
| Decision Making | 2 | 2023 | 204 | 0.300 |
Why?
|
| Logistic Models | 6 | 2021 | 962 | 0.290 |
Why?
|
| Risk Factors | 3 | 2024 | 3449 | 0.280 |
Why?
|
| Residence Characteristics | 3 | 2020 | 256 | 0.280 |
Why?
|
| Health Care Surveys | 4 | 2015 | 247 | 0.270 |
Why?
|
| Referral and Consultation | 4 | 2023 | 180 | 0.270 |
Why?
|
| Children's Health Insurance Program | 2 | 2016 | 2 | 0.270 |
Why?
|
| Cost of Illness | 1 | 2006 | 100 | 0.270 |
Why?
|
| Insurance Claim Review | 3 | 2014 | 70 | 0.260 |
Why?
|
| Software Design | 2 | 2020 | 3 | 0.260 |
Why?
|
| Depression | 3 | 2020 | 518 | 0.260 |
Why?
|
| Aspirin | 2 | 2016 | 67 | 0.250 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 90 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1360 | 0.250 |
Why?
|
| Ethnic Groups | 2 | 2010 | 501 | 0.240 |
Why?
|
| Health Behavior | 1 | 2006 | 374 | 0.230 |
Why?
|
| Risk Management | 1 | 2024 | 5 | 0.230 |
Why?
|
| Medically Underserved Area | 2 | 2014 | 17 | 0.230 |
Why?
|
| Body Mass Index | 6 | 2014 | 974 | 0.230 |
Why?
|
| Interviews as Topic | 7 | 2020 | 327 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 226 | 0.220 |
Why?
|
| Laboratories | 1 | 2023 | 23 | 0.220 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 54 | 0.210 |
Why?
|
| Quality of Health Care | 3 | 2014 | 347 | 0.210 |
Why?
|
| Qualitative Research | 7 | 2020 | 272 | 0.210 |
Why?
|
| Social Justice | 1 | 2002 | 6 | 0.210 |
Why?
|
| Pregnancy in Adolescence | 1 | 2002 | 9 | 0.210 |
Why?
|
| Patient Care Team | 2 | 2020 | 127 | 0.210 |
Why?
|
| Blood Pressure | 1 | 2024 | 310 | 0.200 |
Why?
|
| Community-Based Participatory Research | 2 | 2013 | 63 | 0.200 |
Why?
|
| Patient-Centered Care | 2 | 2014 | 228 | 0.200 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 96 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 127 | 0.190 |
Why?
|
| Accidental Falls | 2 | 2011 | 40 | 0.190 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 23 | 0.180 |
Why?
|
| Perinatal Care | 1 | 2020 | 13 | 0.180 |
Why?
|
| Mentoring | 1 | 2020 | 28 | 0.170 |
Why?
|
| Violence | 1 | 2019 | 30 | 0.170 |
Why?
|
| Food Supply | 1 | 2019 | 36 | 0.170 |
Why?
|
| Social Environment | 1 | 2019 | 90 | 0.160 |
Why?
|
| Vitamin D | 2 | 2017 | 80 | 0.160 |
Why?
|
| Prevalence | 2 | 2019 | 911 | 0.160 |
Why?
|
| Geriatric Assessment | 3 | 2013 | 40 | 0.150 |
Why?
|
| Data Accuracy | 1 | 2018 | 27 | 0.150 |
Why?
|
| Neoplasms | 1 | 2023 | 457 | 0.150 |
Why?
|
| Medical Record Linkage | 2 | 2014 | 44 | 0.150 |
Why?
|
| Politics | 1 | 2017 | 13 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 77 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2020 | 1143 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 22 | 0.150 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 9 | 0.150 |
Why?
|
| Models, Theoretical | 2 | 2014 | 76 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 22 | 0.140 |
Why?
|
| Family Practice | 2 | 2014 | 53 | 0.140 |
Why?
|
| Hispanic Americans | 2 | 2011 | 428 | 0.140 |
Why?
|
| European Continental Ancestry Group | 2 | 2011 | 554 | 0.140 |
Why?
|
| Abortion, Legal | 1 | 2016 | 9 | 0.140 |
Why?
|
| Texas | 1 | 2016 | 35 | 0.140 |
Why?
|
| Preventive Medicine | 1 | 2016 | 25 | 0.140 |
Why?
|
| Confidence Intervals | 2 | 2013 | 253 | 0.140 |
Why?
|
| Inservice Training | 1 | 2015 | 15 | 0.130 |
Why?
|
| African Americans | 2 | 2011 | 490 | 0.130 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2015 | 24 | 0.130 |
Why?
|
| Obesity | 3 | 2013 | 855 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 232 | 0.130 |
Why?
|
| Walking | 2 | 2013 | 87 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 41 | 0.120 |
Why?
|
| Anthropology, Cultural | 1 | 2014 | 8 | 0.120 |
Why?
|
| Health Information Exchange | 1 | 2014 | 4 | 0.120 |
Why?
|
| Community Participation | 2 | 2013 | 33 | 0.120 |
Why?
|
| Propensity Score | 1 | 2015 | 94 | 0.120 |
Why?
|
| Health Information Systems | 1 | 2014 | 4 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2015 | 94 | 0.120 |
Why?
|
| Child Welfare | 1 | 2015 | 40 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2013 | 1314 | 0.120 |
Why?
|
| Incidence | 2 | 2016 | 1314 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 598 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2014 | 2672 | 0.120 |
Why?
|
| Focus Groups | 2 | 2012 | 154 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 17 | 0.120 |
Why?
|
| Viral Vaccines | 1 | 2014 | 15 | 0.120 |
Why?
|
| Washington | 2 | 2005 | 388 | 0.110 |
Why?
|
| Pregnancy Outcome | 3 | 2013 | 159 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 160 | 0.110 |
Why?
|
| Community Health Workers | 1 | 2013 | 15 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 211 | 0.110 |
Why?
|
| Continental Population Groups | 2 | 2015 | 315 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 392 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2012 | 48 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 743 | 0.110 |
Why?
|
| Organizational Case Studies | 1 | 2012 | 25 | 0.110 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2013 | 101 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2013 | 41 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2012 | 48 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2015 | 468 | 0.100 |
Why?
|
| Chlamydia Infections | 1 | 2012 | 27 | 0.100 |
Why?
|
| Vaccination | 2 | 2014 | 674 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2012 | 120 | 0.100 |
Why?
|
| Dental Health Services | 1 | 2011 | 2 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 382 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2013 | 271 | 0.100 |
Why?
|
| Prescriptions | 1 | 2011 | 28 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2011 | 8 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2011 | 13 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 4 | 0.100 |
Why?
|
| Vulnerable Populations | 1 | 2011 | 47 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2011 | 76 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 33 | 0.090 |
Why?
|
| Osteoporotic Fractures | 1 | 2011 | 40 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2011 | 237 | 0.090 |
Why?
|
| Vasospasm, Intracranial | 1 | 2010 | 1 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2010 | 3 | 0.090 |
Why?
|
| Radiology | 1 | 2010 | 9 | 0.090 |
Why?
|
| Income | 2 | 2015 | 98 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2010 | 33 | 0.090 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2010 | 16 | 0.090 |
Why?
|
| Algorithms | 2 | 2013 | 241 | 0.090 |
Why?
|
| Progestins | 1 | 2010 | 28 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 95 | 0.090 |
Why?
|
| Vaccines | 1 | 2013 | 222 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 526 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 136 | 0.090 |
Why?
|
| Quality of Life | 2 | 2010 | 529 | 0.090 |
Why?
|
| Estrogens | 1 | 2010 | 73 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 104 | 0.090 |
Why?
|
| Federal Government | 1 | 2009 | 14 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2009 | 22 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 2003 | 0.080 |
Why?
|
| Centers for Medicare and Medicaid Services (U.S.) | 1 | 2008 | 7 | 0.080 |
Why?
|
| Maternal Welfare | 1 | 2008 | 16 | 0.080 |
Why?
|
| Feedback | 2 | 2020 | 22 | 0.080 |
Why?
|
| Preconception Care | 1 | 2008 | 48 | 0.080 |
Why?
|
| Disease Management | 1 | 2009 | 143 | 0.080 |
Why?
|
| Asthma | 1 | 2010 | 390 | 0.070 |
Why?
|
| Prenatal Care | 1 | 2008 | 134 | 0.070 |
Why?
|
| Indians, North American | 1 | 2006 | 50 | 0.070 |
Why?
|
| Mental Health Services | 2 | 2020 | 161 | 0.070 |
Why?
|
| California | 1 | 2012 | 2365 | 0.070 |
Why?
|
| Asian Americans | 1 | 2006 | 182 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 193 | 0.070 |
Why?
|
| Gestational Age | 3 | 2013 | 119 | 0.060 |
Why?
|
| Forecasting | 1 | 2005 | 80 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 1269 | 0.060 |
Why?
|
| Family Planning Policy | 1 | 2004 | 1 | 0.060 |
Why?
|
| Contraceptive Agents | 1 | 2004 | 7 | 0.060 |
Why?
|
| Contraception | 1 | 2004 | 25 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2004 | 226 | 0.060 |
Why?
|
| Social Isolation | 1 | 2023 | 16 | 0.060 |
Why?
|
| Overweight | 1 | 2005 | 276 | 0.050 |
Why?
|
| Birth Rate | 1 | 2002 | 6 | 0.050 |
Why?
|
| Social Identification | 1 | 2002 | 8 | 0.050 |
Why?
|
| Causality | 1 | 2002 | 43 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2004 | 347 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2014 | 701 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 724 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1173 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 202 | 0.050 |
Why?
|
| Health Promotion | 1 | 2004 | 294 | 0.050 |
Why?
|
| Social Support | 1 | 2022 | 214 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2007 | 567 | 0.050 |
Why?
|
| Clinical Medicine | 1 | 2020 | 5 | 0.050 |
Why?
|
| Workflow | 1 | 2020 | 11 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 256 | 0.040 |
Why?
|
| Aging | 2 | 2011 | 165 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 661 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 342 | 0.040 |
Why?
|
| Planning Techniques | 1 | 2018 | 2 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2018 | 19 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2018 | 65 | 0.040 |
Why?
|
| Grounded Theory | 1 | 2017 | 6 | 0.040 |
Why?
|
| Research | 1 | 2018 | 73 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 346 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2016 | 94 | 0.030 |
Why?
|
| Counseling | 2 | 2010 | 197 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2010 | 1296 | 0.030 |
Why?
|
| Geography, Medical | 1 | 2015 | 5 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 12 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2014 | 54 | 0.030 |
Why?
|
| Contraindications | 1 | 2014 | 15 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2014 | 23 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 83 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2013 | 14 | 0.030 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2013 | 33 | 0.030 |
Why?
|
| Glycated Hemoglobin A | 1 | 2014 | 233 | 0.030 |
Why?
|
| Medical Assistance | 1 | 2013 | 10 | 0.030 |
Why?
|
| Centers for Disease Control and Prevention (U.S.) | 1 | 2013 | 33 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 29 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 399 | 0.030 |
Why?
|
| Geriatrics | 1 | 2013 | 8 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2013 | 134 | 0.030 |
Why?
|
| Patient Participation | 1 | 2014 | 144 | 0.030 |
Why?
|
| Mentors | 1 | 2012 | 12 | 0.030 |
Why?
|
| Data Collection | 1 | 2013 | 275 | 0.030 |
Why?
|
| Medicare | 1 | 2013 | 214 | 0.030 |
Why?
|
| Leadership | 1 | 2012 | 45 | 0.030 |
Why?
|
| Denmark | 1 | 2012 | 19 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 552 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 45 | 0.020 |
Why?
|
| Translational Medical Research | 1 | 2011 | 39 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 81 | 0.020 |
Why?
|
| Calcium Compounds | 1 | 2010 | 4 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2011 | 32 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 17 | 0.020 |
Why?
|
| New York | 1 | 2010 | 22 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 72 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 88 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 114 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 243 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 55 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 74 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2010 | 30 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 168 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2010 | 153 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 62 | 0.020 |
Why?
|
| Software Validation | 1 | 2007 | 1 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2005 | 155 | 0.010 |
Why?
|
| Weight Loss | 1 | 2005 | 321 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1136 | 0.010 |
Why?
|